Characterization of regulatory B cells and IL-10 in response to ischemic reperfusion

https://storage.unitedwebnetwork.com/files/1099/7428ecb76624a9df34e2c812cc4e02a3.pdf
Characterization of regulatory B cells and IL-10 in response to ischemic reperfusion
Yuya
Yamashita
Kensei Taguchi taguchi_kensei@kurume-u.ac.jp Kurume University School of Medicine Division of Nephrology, Department of Internal Medicine Kurume-shi, Fukuoka-ken
Yu-nosuke Yokota yokota_yuunosuke@kurume-u.ac.jp Kurume University School of Medicine Division of Nephrology, Department of Internal Medicine Kurume-shi, Fukuoka-ken
Yuta Mitsuishi mitsuishi_yuuta@kurume-u.ac.jp Kurume University School of Medicine Division of Nephrology, Department of Internal Medicine Kurume-shi, Fukuoka-ken
Tomofumi Moriyama moriyama_tomofumi@kurume-u.ac.jp Kurume University School of Medicine Division of Nephrology, Department of Internal Medicine Kurume-shi, Fukuoka-ken
Sakuya Ito itou_sakuya@kurume-u.ac.jp Kurume University School of Medicine Division of Nephrology, Department of Internal Medicine Kurume-shi, Fukuoka-ken
Goh Kodama kodama_gou@kurume-u.ac.jp Kurume University School of Medicine Division of Nephrology, Department of Internal Medicine Kurume-shi, Fukuoka-ken
Kei Fukami fukami@kurume-u.ac.jp Kurume University School of Medicine Division of Nephrology, Department of Internal Medicine Kurume-shi, Fukuoka-ken
 
 
 
 
 
 
 
 

Acute kidney injury (AKI) occurs in up to 20% of hospitalized patients. Interleukin-10 (IL-10), an anti-inflammatory cytokine, modulates the progression of AKI via reducing pro-inflammatory cytokines including TNF-a and IL-6. Regulatory B cells (Breg) is considered a main source of IL-10. Breg is a subset with a CD1dhiCD5+CD19hi phenotype and comprises 1-3% of B cells in mouse spleen with smaller numbers in the blood, lymph nodes, intestine, and peritoneum under basal condition. However, the distribution of Breg in response to AKI remains unknown. Thus, we investigated Breg infiltration into ischemic reperfusion (IR) kidneys and examined the expression pattern of IL-10-producing cells.

Experiment 1; To study if Breg infiltrates into IR kidneys, IR was constructed by clamping left renal artery for 30 minutes in IL-10-IRES-GFP mice. The kidneys were isolated on day1, 7, 14, 28, 42, and 56 after the surgery. Breg expression was examined by immunofluorescence staining. IL-10 expression was evaluated by real-time PCR. Experiment 2; A splenectomy was performed 7 days before ischemia IR surgery to investigate if splenectomy inhibits Breg infiltration.

IL-10 was increased immediately after IR surgery and sustained until day7 in parallel with an increase in tubular injury. We identified that splenectomy did not attenuate renal dysfunction and fibrosis without any change in serum IL-10. Also, the increase in renal IL-10 mRNA was not altered by splenectomy. Large scan images demonstrated that number of interstitial GFP+ cells in IR kidneys was increased from day7 when compared to sham kidneys and remained high until chronic phase. We also found that GFP signal in mesangial area of uninjured kidneys; however, the GFP expression disappeared after IR surgery. This finding indicates that mesangial cells in IR kidneys might produce IL-10 which is inhibited by IR injury.

We identified that IL-10 mRNA is upregulated in response to IR injury with an increase in number of interstitial GFP+ cells. Mesangial cells might be capable of producing IL-10 which is inhibited by IR injury. Renal infiltration of IL-10-producing cells may be independent of spleen.

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos